Secreted Aβ does not mediate neurotoxicity by antibody-stimulated amyloid precursor protein

被引:30
作者
Sudo, H [1 ]
Hashimoto, Y [1 ]
Niikura, T [1 ]
Shao, ZJ [1 ]
Yasukawa, T [1 ]
Ito, Y [1 ]
Yamada, M [1 ]
Hata, M [1 ]
Hiraki, T [1 ]
Kawasumi, M [1 ]
Kouyama, K [1 ]
Nishimoto, I [1 ]
机构
[1] Keio Univ, Sch Med, Dept Pharmacol & Neurosci, Shinjuku Ku, Tokyo 1608582, Japan
关键词
amyloid precursor protein; antibody-induced neuronal death; A beta polypeptide; glutathione; cytoplasmic domain; Alzheimer's disease;
D O I
10.1006/bbrc.2001.4604
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antibodies against APP, a precursor of A beta deposited in Alzheimer's disease brain, have been shown to cause neuronal death. Therefore, it is important to determine whether A beta mediates antibody-induced neurotoxicity. When primary neurons were treated with anti-APP antibodies, A beta 40 and A beta 42 in the cultured media were undetectable by an assay capable of detecting 100 nM A beta peptides. However, exogenously treated A beta1-42 or A beta1-43 required >3 muM to exert neurotoxicity, and 25 muM A beta1-40 was not neurotoxic. Glutathione-ethyl-ester inhibited neuronal death by anti-APP antibody, but not death by A beta1-42, whereas serum attenuated toxicity by A beta1-42, but not by anti-APP antibody. Using immortalized neuronal cells, we specified the domain responsible for toxicity to be cytoplasmic His(657)-Lys(676), but not the A beta1-42 region, of APP. This indicates that neuronal cell death by anti-APP antibody is not mediated by secreted A beta. (C) 2001 Academic Press.
引用
收藏
页码:548 / 556
页数:9
相关论文
共 41 条
[1]  
Brouillet E, 1999, J NEUROSCI, V19, P1717
[2]   RAPID INDUCTION OF ALZHEIMER A-BETA AMYLOID FORMATION BY ZINC [J].
BUSH, AI ;
PETTINGELL, WH ;
MULTHAUP, G ;
PARADIS, MD ;
VONSATTEL, JP ;
GUSELLA, JF ;
BEYREUTHER, K ;
MASTERS, CL ;
TANZI, RE .
SCIENCE, 1994, 265 (5177) :1464-1467
[3]   Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation [J].
Chui, DH ;
Tanahashi, H ;
Ozawa, K ;
Ikeda, S ;
Checler, F ;
Ueda, O ;
Suzuki, H ;
Araki, W ;
Inoue, H ;
Shirotani, K ;
Takahashi, K ;
Gallyas, F ;
Tabira, T .
NATURE MEDICINE, 1999, 5 (05) :560-564
[4]   A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1 [J].
Crook, R ;
Verkkoniemi, A ;
Perez-Tur, J ;
Mehta, N ;
Baker, M ;
Houlden, H ;
Farrer, M ;
Hutton, M ;
Lincoln, S ;
Hardy, J ;
Gwinn, K ;
Somer, M ;
Paetau, A ;
Kalimo, H ;
Ylikoski, R ;
Pöyhönen, M ;
Kucera, S ;
Haltia, M .
NATURE MEDICINE, 1998, 4 (04) :452-455
[5]   Alzheimer's disease - Etiologies, pathophysiology, cognitive reserve, and treatment opportunities [J].
Cummings, JL ;
Vinters, HV ;
Cole, GM ;
Khachaturian, ZS .
NEUROLOGY, 1998, 51 (01) :S2-S17
[6]   Panel discussion [J].
Cummings, JL ;
Geula, C ;
Kaye, J ;
Dunkin, J ;
Menken, M ;
Taylor, P ;
Farlow, M .
NEUROLOGY, 1998, 51 (01) :S65-S67
[7]  
Esler WP, 1996, J NEUROCHEM, V66, P723
[8]   CODON-618 VARIANT OF ALZHEIMER AMYLOID GENE ASSOCIATED WITH INHERITED CEREBRAL-HEMORRHAGE [J].
FERNANDEZMADRID, I ;
LEVY, E ;
MARDER, K ;
FRANGIONE, B .
ANNALS OF NEUROLOGY, 1991, 30 (05) :730-733
[9]   G protein beta gamma complex-mediated apoptosis by familial Alzheimer's disease mutant of APP [J].
Giambarella, U ;
Yamatsuji, T ;
Okamoto, T ;
Matsui, T ;
Ikezu, T ;
Murayama, Y ;
Levine, MA ;
Katz, A ;
Gautam, N ;
Nishimoto, I .
EMBO JOURNAL, 1997, 16 (16) :4897-4907
[10]   Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F•DP, in B-amyloid-induced neuronal death [J].
Giovanni, A ;
Wirtz-Brugger, F ;
Keramaris, E ;
Slack, R ;
Park, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19011-19016